Humes Jennifer reported tax withholding involving 3,880 shares of Roivant Sciences Ltd. at $39.77 for −$154k on Sep 20, 2026

Tax withholding
Form 4 code F. Payment of an exercise price or tax liability by delivering or withholding securities in a Rule 16b-3 transaction.
Chief Accounting Officer
Chief Accounting Officer
Filed Sep 22, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$154,307.60Shares × reported price
Shares traded
3,880Common Shares
Price per share
$39.77Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
106,419Direct
Trade date
Sep 20, 2026Tax withholding
Filed
Sep 22, 2026, 9:00 PM ET3-day reporting delay
Accession
0001140361-26-037363Code F · Transaction 227991
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

ROIV price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
ROIV · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago −1.4%1w ago +11%1d ago +8%
Returns since7d −0.7%30d +1.7%90d180d1y

Footnotes in full

F1: Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such RSUs. F2: Includes Common Shares purchased under the Company's Employee Stock Purchase Plan.